World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
72
Citations
17324
World Ranking
1762
National Ranking
750

Medicine

D-Index
72
Citations
17446
World Ranking
19862
National Ranking
9892

Clyde S. Crumpacker publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Clyde S. Crumpacker sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 202 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Clyde S. Crumpacker D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Clyde S. Crumpacker sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 72 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Clyde S. Crumpacker is primarily affiliated with Beth Israel Deaconess Medical Center in the United States. Their research spans multiple disciplines within biomedical science, focusing on immunology, microbiology, biochemistry, genetics, molecular biology, and medicine. The scientist's work emphasizes understanding immune responses, infectious diseases, and vaccine development, particularly in the context of viral infections such as HIV and SARS-CoV-2.

The main fields of study for Crumpacker include:

  • Immunology and Microbiology
  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Their subfields of study focus on:

  • Molecular Biology
  • Virology
  • Infectious Diseases
  • Immunology

Prominent topics covered in their research include:

  • HIV Research and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Vaccines and Immunoinformatics Approaches
  • Immune Responses and Vaccinations
  • Epigenetics and DNA Methylation
  • RNA Modifications and Cancer

Crumpacker has contributed to recent scientific literature with a series of papers primarily authored by Jielin Zhang, indicating frequent collaboration. The recent publications are:

  • "HIV UTR, LTR, and Epigenetic Immunity," 2022, Viruses
  • "Systems Vaccinology in HIV Vaccine Development," 2022, Vaccines
  • "Approaches to pandemic prevention - the chromatin vaccine," 2023, Frontiers in Immunology
  • "A Leap Forward in Vaccinology by cVacc Elicited Epigenetic Immunity," 2025, Preprints.org

Frequent collaborators with Crumpacker include:

  • Jielin Zhang
  • Philip W. Askenase
  • Rudolf Jaenisch

The scientist's work appears regularly in specialized venues such as:

  • Viruses
  • Vaccines
  • Frontiers in Immunology
  • Preprints.org

Crumpacker's research involves exploring vaccine development through systems vaccinology, epigenetic immunity related to HIV, and strategies for pandemic prevention. Their multidisciplinary approach integrates molecular biology techniques with immunological insights to address infectious disease challenges.

Best Publications

  • Infective Endocarditis: An Analysis Based on Strict Case Definitions

    C. Fordham Von Reyn;Barry S. Levy;Robert D. Arbeit;Gerald Friedland

  • Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

    Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston

  • Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study.

    Martin Markowitz;Bach-Yen Nguyen;Eduardo Gotuzzo;Fernando Mendo

  • Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

    Kim S. Erlich;John Mills;Pamela Chatis;Gregory J. Mertz

  • A Controlled Trial Comparing Continued Zidovudine with Didanosine in Human Immunodeficiency Virus Infection

    Kahn Jo;Lagakos Sw;Richman Dd;Cross A

  • Resistance to Antiviral Drugs of Herpes Simplex Virus Isolated from a Patient Treated with Acyclovir

    Clyde S. Crumpacker;Lowell E. Schnipper;Steven I. Marlowe;Patricia N. Kowalsky

  • A Controlled Trial Comparing Foscarnet with Vidarabine for Acyclovir-Resistant Mucocutaneous Herpes Simplex in the Acquired Immunodeficiency Syndrome

    Sharon Safrin;Clyde Crumpacker;Pam Chatis;Roger Davis

  • Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human Infections

    Clyde S. Crumpacker;Lowell E. Schnipper;John A. Zaia;Myron J. Levin

  • Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group.

    W L Drew;D Ives;J P Lalezari;C Crumpacker

  • Ribavirin antagonizes the effect of azidothymidine on HIV replication

    Markus W. Vogt;Kevan L. Hartshorn;Phillip A. Furman;Ting-Chao Chou

  • Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy

    Richard T. D'Aquila;Victoria A. Johnson;Seth L. Welles;Anthony J. Japour

  • Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci

    Lowell E. Schnipper;Clyde S. Crumpacker

  • Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.

    Chiang J. Li;Lin J. Zhang;Bruce J. Dezube;Clyde S. Crumpacker

  • Nonresponsiveness to Hepatitis B Vaccine in Health Care Workers: Results of Revaccination and Genetic Typings

    D E Craven;Z L Awdeh;L M Kunches;E J Yunis

  • Successful Treatment with Foscarnet of an Acyclovir-Resistant Mucocutaneous Infection with Herpes Simplex Virus in a Patient with Acquired Immunodeficiency Syndrome

    P.A. Chatis;C.H. Miller;L.E. Schrager;C.S. Crumpacker

  • Hepatitis B Vaccine in Health Care Personnel: Safety, lmmunogenicity, and Indicators of Efficacy

    Jules L. Dienstag;Barbara G. Werner;B. Frank Polk;David R. Snydman

  • Mechanism of action of foscarnet against viral polymerases.

    Clyde S. Crumpacker

  • Progressive polyradiculopathy in acquired immune deficiency syndrome

    David Eidelberg;Ana Sotrel;Hannes Vogel;Paul Walker

  • Association of Plasma Human Immunodeficiency Virus Type 1 RNA Level with Risk of Clinical Progression in Patients with Advanced Infection

    R. W. Coombs;S. L. Welles;C. Hooper;P. S. Reichelderfer

  • Cytomegalovirus Infection Causes an Increase of Arterial Blood Pressure

    Jilin Cheng;Qingen Ke;Zhuang Jin;Haibin Wang

  • Recurrence and Resistance Patterns of Herpes Simplex Virus following Cessation of ⩾6 Years of Chronic Suppression with Acyclovir

    Kenneth H. Fife;Clyde S. Crumpacker;Gregory J. Mertz;Edgar L. Hill

Frequent Co-Authors

Myron J. Levin
Myron J. Levin University of Colorado Anschutz Medical Campus
David R. Snydman
David R. Snydman Tufts Medical Center
Bruce J. Dezube
Bruce J. Dezube Beth Israel Deaconess Medical Center
Stephen A. Spector
Stephen A. Spector University of California, San Diego
Akira Matsumori
Akira Matsumori International Society of Cardiomyopathy , Myocarditis, and Heart Failure
Richard Platt
Richard Platt Harvard University
Donald E. Craven
Donald E. Craven Tufts University
Jules L. Dienstag
Jules L. Dienstag Harvard University
Arthur B. Pardee
Arthur B. Pardee Harvard University
Adriana Weinberg
Adriana Weinberg University of Colorado Anschutz Medical Campus

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology often opens doors to diverse career paths, especially when combined with complementary online degrees. For individuals with unique backgrounds, including those seeking options for second chances, degrees for felons can offer accessible stepping stones into science-related fields.

Healthcare roles such as a functional medicine nurse practitioner combine biological knowledge with patient care, offering rewarding career trajectories paired with competitive salaries. Meanwhile, the growing field of health information management emphasizes data accuracy and security in healthcare settings, making it an attractive path with promising healthcare information management salary prospects.

Another vital area connected to microbiology and healthcare is medical coding. Becoming a certified professional coder (CPC) requires mastering medical terminology and coding systems, paving the way for stable job opportunities in healthcare administration.

By integrating microbiology studies with these related online degrees and career pathways, students can enhance their employability, explore interdisciplinary roles, and adapt to evolving healthcare industry demands.

Learn more about degrees for felons, the functional medicine nurse practitioner salary, becoming a certified professional coder (CPC), and insights on healthcare information management salary.

Best Scientists Citing Clyde S. Crumpacker

Trending Scientists